NBMI 300 mg (n = 11) | NBMI 100 mg (n = 13) | Placebo (n = 12) | |
---|---|---|---|
Mercury in urine [μg/l]a | |||
Screening | 26.5 (4.22–321.0) | 39.1 (12.6–160.0) | 9.16 (1.7–230.0) |
Day 15 | 18.5 (2.1–131) | 37.7 (8.1–132.0) | 13.9 (1.3–161.0) |
Day 45 | 14.2 (1.8–226.0) | 39.1 (2.6–96.1) | 11.3 (1.3–275.0) |
Mercury in urine [μg/g creatinine]a | |||
Screening | 62.4 (7.6–773.2) | 66.7 (12.4–200) | 18.7 (2.6–488.5) |
Day 15 | 65.2 (2.6–298.0) | 64.4 (17.2–241.0) | 29.75 (1.8–536.7) |
Day 45 | 34.8 (2.9–1883.3) | 53.3 (13.2–340.2) | 9.86 (0.4–1797.4) |
Mercury in plasma [μg/l]a | |||
Screening | 5.8 (1.3–95.9) | 6.4 (1.7–25.8) | 6.1 (1.4–45.8) |
Day 15 | 6.8 (1.7–64.4) | 8.0 (2.6–33.6) | 5.1 (1.5–42.9) |
Day 45 | 6.4 (1.8–49.0) | 9.3 (1.6–42.2) | 5.9 (1.0–90.1) |